PriviteraMD. Clinical rules for phenytoin dosing. Ann Pharmacother1993; 27: 1169–73.
2.
GuglerRAzarnoffDLShoemanDW. Diphenylhydantoin: Correlation between protein binding and albumin concentration. Klin Wochenschr1975; 53: 445–6.
3.
ReidenbergMMOdar-CederlofIVon BarhCBorgaOSjoqvistF. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med1971; 285: 264–7.
4.
PeruccaERichensA. Drug interactions with phenytoin. Drugs1981; 21: 120–37.
5.
TolerSMWilkersonMAPorterWHSmithAJChandlerMHH. Severe phenytoin intoxication as a result of altered protein binding in AIDS. DICP Ann Pharmacother1990; 24: 698–700.
6.
PetersonGMMcLeanSvon WittRSMillingenKS. Audit of a monitoring service for free phenytoin. Br J Clin Pharmacol1985; 19: 693–7.
7.
WilkinsonGR. Clearance approaches in pharmacology. Pharmacol Rev1987; 39: 1–47.
8.
QuandtCMFreemanCMHorstHMEliasSB. Plasma protein binding of phenytoin in critically patients (abstract). Drug Intell Clin Pharm1983; 17: 438.
